CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA® [Alpha1-Proteinase Inhibitor (Human)]
Advertisement
New vial options deliver on CSL Behring's heritage of innovation by providing more alternatives to patients